BAP1 and nonpapillary renal cell carcinoma: For example, ccRCC with BRCA1-associated protein-1 (BAP1) mutation presents increased sensitivity to radiation therapy and greater sensitivity to the inhibitors of mammalian target of rapamycin complex 1 (mTORC1 inhibitors) [3,34].